Boston Scientific Inc. (BSX): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific ( BSX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.4%. By the end of trading, Boston Scientific rose $0.14 (1.3%) to $11.28 on average volume. Throughout the day, 13,105,950 shares of Boston Scientific exchanged hands as compared to its average daily volume of 16,187,100 shares. The stock ranged in a price between $11.12-$11.39 after having opened the day at $11.12 as compared to the previous trading day's close of $11.14. Other companies within the Health Services industry that increased today were: Response Genetics ( RGDX), up 27.1%, Spherix ( SPEX), up 22.4%, Uroplasty ( UPI), up 8.0% and ZELTIQ Aesthetics ( ZLTQ), up 7.9%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $15.0 billion and is part of the health care sector. Shares are up 95.1% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall.

On the negative front, Escalon Medical Corporation ( ESMC), down 6.1%, IsoRay ( ISR), down 5.2%, Stereotaxis ( STXS), down 5.0% and Daxor Corporation ( DXR), down 4.7% , were all laggards within the health services industry with Catamaran ( CTRX) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

These Stocks Are Ready to Reverse Course

Modi's Visit to Meet Trump Focuses Big Spotlight on the H-1B Visa Debate

Cramer: These Sectors Look Bullish (Part III)